decisionhealth Newsletters, Part B News - 2020 Issue 3 (March)
CDC issues extended guidance on how to code COVID-19 cases, lab panels
Subscribe or sign in to view the full article.
Article Overview
This article covers interim CDC and CMS guidance issued early in the COVID-19 public health response, including how the CDC directed clinicians and coders to report suspected or confirmed illness patterns and exposure scenarios, and how CMS introduced a new HCPCS laboratory test code. It is relevant to coders, billers, compliance staff, and laboratory/facility teams who need to understand the evolving coding environment, public health reporting implications, and the distinction between U.S. and WHO code set usage.
Why This Topic Matters
COVID-19 coding guidance changed rapidly in early 2020, and this article helps readers track the interim instructions, new laboratory billing code, and related federal guidance affecting claims and reporting workflows.
Article Sections
-
CDC interim guidance for COVID-19 case reporting
Introduces the CDC’s temporary coding guidance issued before the new diagnosis code became available. Covers the general reporting approach for COVID-19-related illness and exposure scenarios.
-
Illness presentations linked to COVID-19
Summarizes the article’s discussion of several respiratory presentations associated with COVID-19 and the broader CDC guidance for reporting them during the interim period.
-
Exposure, symptoms, and suspected cases
Discusses guidance for situations involving possible exposure, suspected illness, and symptom-only reporting when a definitive diagnosis has not yet been established.
-
Laboratory testing update
Explains the CMS update affecting billing for COVID-19 laboratory testing and the related administrative timing for claims processing.
-
WHO emergency code and U.S. reporting context
Notes the separate WHO emergency coding action and the article’s discussion of how that code set differs from U.S. reporting guidance.
What You Will Learn
- How interim federal guidance addressed COVID-19 diagnosis reporting during the early outbreak period
- What kinds of COVID-19-related clinical presentations were covered in the update
- How exposure and symptom-only scenarios were addressed in the guidance
- What changed for laboratory testing claims and billing workflows
- How WHO and U.S. code set guidance differed in this period
Who Should Read This
- Medical coders
- Medical billers
- Compliance professionals
- Laboratory billing staff
- Health information management professionals
- Facility administrators
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com